Search by Drug Name or NDC

    NDC 63304-0192-30 Desvenlafaxine 100 mg/1 Details

    Desvenlafaxine 100 mg/1

    Desvenlafaxine is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sun Pharmaceutical Industries, Inc.. The primary component is DESVENLAFAXINE.

    Product Information

    NDC 63304-0192
    Product ID 63304-192_cd04a0b2-a7f2-4629-997f-af2a8e65f15b
    Associated GPIs 58180020007540
    GCN Sequence Number 070830
    GCN Sequence Number Description desvenlafaxine TAB ER 24H 100 MG ORAL
    HIC3 H7C
    HIC3 Description SEROTONIN-NOREPINEPHRINE REUPTAKE-INHIB (SNRIS)
    GCN 34482
    HICL Sequence Number 040202
    HICL Sequence Number Description DESVENLAFAXINE
    Brand/Generic Generic
    Proprietary Name Desvenlafaxine
    Proprietary Name Suffix n/a
    Non-Proprietary Name Desvenlafaxine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 100
    Active Ingredient Units mg/1
    Substance Name DESVENLAFAXINE
    Labeler Name Sun Pharmaceutical Industries, Inc.
    Pharmaceutical Class Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA204150
    Listing Certified Through 2024-12-31

    Package

    NDC 63304-0192-30 (63304019230)

    NDC Package Code 63304-192-30
    Billing NDC 63304019230
    Package 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-192-30)
    Marketing Start Date 2013-03-05
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 4.24993
    Pricing Unit EA
    Effective Date 2021-08-18
    NDC Description DESVENLAFAXINE ER 100 MG TAB
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 4, 6
    Classification for Rate Setting G
    As of Date 2022-08-10
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis